Dr Reddy's Slapped Rs 2.19 Crore GST Demand for FY20-22, Plans to Challenge Orders

Written By :  Parthika Patel
Published On 2026-03-19 18:08 GMT   |   Update On 2026-03-19 18:08 GMT

Hyderabad: Dr. Reddy's Laboratories Limited has received three separate tax demand orders from the Goods and Services Tax (GST) authority for the financial years 2019-20 to 2021-22, the company informed in a regulatory filing.

The orders have been issued by the Commercial Taxes Department, Office of the Joint Commissioner (ST), Chennai Intelligence-II, under Section 74 of the Tamil Nadu Goods and Services Tax (TNGST) Act, 2017, which pertains to tax demands along with interest and penalties.

According to the company, the action has been taken on the grounds that certain supplies were considered taxable by the authorities. Consequently, penalties have been imposed across the three financial years.

The penalty for FY 2019–20 stands at ₹2,19,48,944, while ₹50,406 and ₹4,384 have been levied for FY 2020–21 and FY 2021–22, respectively.

The company stated that it received the orders on March 16, 2026. Despite the development, Dr. Reddy’s clarified that there is no material impact expected on its financials, operations, or overall business activities.

Further, the pharmaceutical major noted that it is evaluating the orders and may file an appeal before the appropriate appellate authority.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News